Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

China flag China · Delayed Price · Currency is CNY
46.69
+0.17 (0.37%)
Dec 5, 2025, 3:00 PM CST
-39.36%
Market Cap 59.07B
Revenue (ttm) 1.80B
Net Income (ttm) -333.84M
Shares Out 1.27B
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,001,993
Average Volume 3,178,050
Open 46.50
Previous Close 46.52
Day's Range 45.69 - 46.75
52-Week Range 45.69 - 80.00
Beta 1.39
RSI 18.63
Earnings Date Mar 20, 2026

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells in vitro diagnostic reagents and instruments, and vaccines in China and internationally. It operates through Diagnostics Division and Vaccine Division segments. The company offers chemiluminescence detection, biochemical, hepatitis B core antibody detection, and HIV reagents; rapid urine tests for hepatitis E antigen; chronic disease management, hepatitis E screening and prevention, women’s full life-cycle health management, smart laboratories, medic... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 3,790
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603392
Full Company Profile

Financial Performance

In 2024, SHA:603392's revenue was 2.25 billion, a decrease of -59.25% compared to the previous year's 5.51 billion. Earnings were 106.24 million, a decrease of -91.49%.

Financial Statements

News

There is no news available yet.